Zhao, L.; Wang, Y.; Sun, X.; Zhang, X.; Simone, N.; He, J.
ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2024, 25, 2382.
https://doi.org/10.3390/ijms25042382
AMA Style
Zhao L, Wang Y, Sun X, Zhang X, Simone N, He J.
ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2024; 25(4):2382.
https://doi.org/10.3390/ijms25042382
Chicago/Turabian Style
Zhao, Lei, Yifang Wang, Xin Sun, Xiujuan Zhang, Nicole Simone, and Jun He.
2024. "ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 25, no. 4: 2382.
https://doi.org/10.3390/ijms25042382
APA Style
Zhao, L., Wang, Y., Sun, X., Zhang, X., Simone, N., & He, J.
(2024). ELK1/MTOR/S6K1 Pathway Contributes to Acquired Resistance to Gefitinib in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 25(4), 2382.
https://doi.org/10.3390/ijms25042382